• Dr. Mala Kumari

Indeed, the rise of antimicrobial resistance is a significant global concern. The discovery of new active compounds against novel targets is crucial to combat this issue. Copper complexes have been found to often demonstrate enhanced biological activity compared to the parent ligand alone. The use of copper complexes in the form of drugs can modify their pharmacological and toxicological properties. Low molecular weight copper complexes (Cu2+) have been proven beneficial against several diseases such as tuberculosis, rheumatoid arthritis, gastric ulcers, and cancers. Here in this the biological activity of copper complexes with 2.9-dimethyl 1,10-phenanthroline (dmp) and 4-NOHA as a secondary ligand were synthesized and characterized by and as a primary ligand .The copper(II) complexes are redox active and its electrochemical behavior are studied by cyclic voltammetry technique, cyclic voltammograms were recorded in dimethyl sulfoxide (DMSO) and dimethylformamide (DMF).

Copper ,toxilogy, cytotoxicity antimicrobilal ,biological activity, electrochemical behaviour

"Electrochemical and Microbial Behaviour of Cu(II)Complexes N,N’-Diimine and Heterocyclic Ligand in Non Aqueous Solvents", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 3, page no.f265-f276, March-2024, Available :http://www.jetir.org/papers/JETIR2403531.pdf

"Electrochemical and Microbial Behaviour of Cu(II)Complexes N,N’-Diimine and Heterocyclic Ligand in Non Aqueous Solvents", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 3, page no. ppf265-f276, March-2024, Available at : http://www.jetir.org/papers/JETIR2403531.pdf